High coverage of diverse invasive meningococcal serogroup B strains by the 4-component vaccine 4CMenB in Australia, 2007–2011: Concordant predictions between MATS and genetic MATS

Meningococcal serogroup B (MenB) accounts for an important proportion of invasive meningococcal disease (IMD). The 4-component vaccine against MenB (4CMenB) is composed of factor H binding protein (fHbp), neisserial heparin-binding antigen (NHBA), Neisseria adhesin A (NadA), and outer membrane vesic...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Sarah J. Tozer, Helen V. Smith, David M. Whiley, Ray Borrow, Giuseppe Boccadifuoco, Duccio Medini, Davide Serruto, Marzia Monica Giuliani, Maria Stella, Rosita De Paola, Alessandro Muzzi, Mariagrazia Pizza, Theo P. Sloots, Michael D. Nissen
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Taylor & Francis Group 2021-09-01
סדרה:	Human Vaccines & Immunotherapeutics
נושאים:	meningococcal serogroup b 4cmenb mats gmats strain coverage australia
גישה מקוונת:	http://dx.doi.org/10.1080/21645515.2021.1904758
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!